about
Effects of Exercise Interventions and Physical Activity Behavior on Cancer Related Cognitive Impairments: A Systematic ReviewEffects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTsExercise medicine for advanced prostate cancer.A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial.Living with prostate cancer: randomised controlled trial of a multimodal supportive care intervention for men with prostate cancer.The potential role of exercise in neuro-oncologyLifestyle factors, medication use and risk for ischaemic heart disease hospitalisation: a longitudinal population-based study.Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies.Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation.Implementing exercise in cancer care: study protocol to evaluate a community-based exercise program for people with cancer.Physical Activity and Survival among Long-term Cancer Survivor and Non-Cancer Cohorts.Men's help-seeking in the first year after diagnosis of localised prostate cancer.Evidence-based physical activity guidelines for cancer survivors: current guidelines, knowledge gaps and future research directions.Exercise therapy for sexual dysfunction after prostate cancer.Can exercise suppress tumour growth in advanced prostate cancer patients with sclerotic bone metastases? A randomised, controlled study protocol examining feasibility, safety and efficacy.Enhancing active surveillance of prostate cancer: the potential of exercise medicine.Evaluation of resistance training to improve muscular strength and body composition in cancer patients undergoing neoadjuvant and adjuvant therapy: a meta-analysis.Functional benefits are sustained after a program of supervised resistance exercise in cancer patients with bone metastases: longitudinal results of a pilot study.Exercise as medicine in the management of pancreatic cancer: a case study.Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.Supervised physical exercise improves VO2max, quality of life, and health in early stage breast cancer patients: a randomized controlled trial.Is it safe and efficacious for women with lymphedema secondary to breast cancer to lift heavy weights during exercise: a randomised controlled trial.Neither heavy nor light load resistance exercise acutely exacerbates lymphedema in breast cancer survivor.Prospective study of exercise intervention in prostate cancer patients on androgen deprivation therapy.Long-term effects of intermittent androgen suppression on testosterone recovery and bone mineral density: results of a 33-month observational study.Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: a randomized controlled trial.Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.Plasma Abeta42 correlates positively with increased body fat in healthy individuals.Resistance training and cancer survival.Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial.Health-related quality of life and pelvic floor dysfunction in advanced-stage ovarian cancer survivors: associations with objective activity behaviors and physiological characteristics.Compliance to exercise-oncology guidelines in prostate cancer survivors and associations with psychological distress, unmet supportive care needs, and quality of life.Activity Behaviors and Physiological Characteristics of Women With Advanced-Stage Ovarian Cancer: A Preliminary Cross-sectional Investigation.Short-term preoperative exercise training: should we expect long-term benefits without postoperative exercise stimulus?A Physiological Profile of Ovarian Cancer Survivors to Inform Tailored Exercise Interventions and the Development of Exercise Oncology Guidelines.Randomized controlled trial of a peer led multimodal intervention for men with prostate cancer to increase exercise participation.Should resistance training be targeted to a specific subgroup of patients with non-small cell lung cancer?The feasibility of a pragmatic distance-based intervention to increase physical activity in lung cancer survivors.Associations between aerobic exercise levels and physical and mental health outcomes in men with bone metastatic prostate cancer: a cross-sectional investigation.The effect, moderators, and mediators of resistance and aerobic exercise on health-related quality of life in older long-term survivors of prostate cancer.
P50
Q26752851-214C2710-2B45-4CF4-B6D5-BEF4737A2ED8Q28078511-F743F280-959A-40D0-98CD-DC26630BF377Q30491827-E8A81FD1-1E20-4111-8212-03BA831EE233Q30936900-2C811597-1CB5-4EB4-8D65-A31D03E61E7CQ33972182-9965949A-E255-456C-9465-C7129B9320BEQ34473328-ABD90043-EAB0-44BD-9FE5-CB7A3AA786F7Q35023454-C7CC2BE8-1EC8-4450-BEAC-FCB8282DE8C7Q35123662-CC185097-6B92-4F0B-8578-09E184BE84D9Q36260964-1607E4C6-2A16-47A4-B8B9-F0E25F2E5C51Q36272114-FAF46C3E-1561-4028-BA1E-CE9443BAD412Q37639702-59133355-13C9-43F0-981A-D2DBEFF0500AQ37696593-F06BD9F3-6FA5-4343-9C15-FD962803855AQ38122851-96644283-D357-4AAD-8EBE-B778FA34FB2CQ38150112-7E4D3FD7-BC88-4F27-8645-5AC2FC34E9D2Q38676999-7C073732-B1D5-497F-A6A0-CA15D7BB6FBCQ38765391-6046D012-4F35-4AC1-BE07-ECFE39BD91BCQ39067972-36720BC5-986C-4FC4-9CB5-339ED13E4BCCQ39272429-3B99BD5C-A9C0-44E3-811D-73C87E324FC5Q39348922-550A099B-FD91-4706-AF61-19E120279014Q40057603-0B04B5ED-361A-490A-8BF6-2233A343F475Q41465790-9F6776A9-0EDA-41F9-8FF8-81DDFB73887DQ44073955-61AEC377-D2D6-4AA9-A8E8-24632E5C1668Q44717878-4DB3A2D1-67A5-4A25-81AA-3993A38DD9BDQ45377473-4165AA70-66B2-42CC-94C0-A8ADC1E19BF0Q46090898-F3B5EE3A-ED57-4A98-9D5E-2C00BD4F6675Q46458293-E64DAC86-DE5A-4C62-92BB-C5DF373BD749Q46705671-2EE17FCA-0806-4FF6-AC55-D13331D6E51CQ46844495-0E8F38F5-ADF6-4F7A-A0EE-AB8E3AB3F279Q46876022-42410577-A89C-46C3-B917-3F34A5AC1188Q47427787-2F05A6DE-8A3B-4B95-BD1A-AD6F5E413790Q47549793-CB17E060-BA57-439A-90EA-D23B452431C3Q47639569-D4C5FAD6-EAC1-44C0-B682-956735FA2130Q47712749-4AA79E6F-8DB5-415F-AF3E-F76778DACB54Q47753908-BD03753D-0AAA-421E-BF60-61F6DDC98E8FQ47786954-E3E51455-9274-43F5-8358-7A396E2AD6E9Q47792340-1C0BD671-157A-45B1-AAEA-EBC0D2F0B41AQ47827130-F467EF33-30D5-42A9-9DC1-985163C4FDD9Q47867807-D3994F71-3962-4ABF-9FE5-202D9AFC8E8FQ47933630-F377B119-3952-47EC-9972-7B00EFF983FCQ48040540-4D20D1B0-8DFA-4CDC-997A-1C09789B19EB
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Daniel A Galvão
@en
Daniel A Galvão
@nl
type
label
Daniel A Galvão
@en
Daniel A Galvão
@nl
altLabel
Galvão DA
@en
prefLabel
Daniel A Galvão
@en
Daniel A Galvão
@nl
P31
P496
0000-0002-8209-2281